We are live on
!
Find out more
ACM
Altium Capital Management Portfolio holdings
AUM
$42M
This Fund
S&P 500
This Quarter
Est. Return
+96.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$628K
AUM Growth
–
Cap. Flow
+$451K
Cap. Flow
% of AUM
71.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Plus Therapeutics
PSTV
|
+$451K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Plus Therapeutics
PSTV
$26.4M
| $628K | 100% |
+36,757
| New | +$451K |
|
Similar funds
TA
SIM
LSA
VEPM
GC
VI
BCM
VAM
Altium Capital Management's Q3 2025 Portfolio in Review
Q3 2025 is the first quarter with a 13F filing on record for Altium Capital Management, which disclosed 1 position worth $628K. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Plus Therapeutics: 36,757 shares worth $628K.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Altium Capital Management's largest Q3 2025 buy was Plus Therapeutics: 36,757 shares worth $628K.
- Altium Capital Management's ten largest holdings make up 100% of its $628K portfolio in Q3 2025.
- Altium Capital Management disclosed 1 position in Q3 2025, its first 13F filing on record.
Based on Altium Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.